Gene: ESCO2
Official Full Name: establishment of sister chromatid cohesion N-acetyltransferase 2provided by HGNC
Gene Summary: This gene encodes a protein that may have acetyltransferase activity and may be required for the establishment of sister chromatid cohesion during the S phase of mitosis. Mutations in this gene have been associated with Roberts syndrome. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17888 | ESCO2 Knockout cell line (HeLa) | Human | ESCO2 | 1:3~1:6 | Negative | Online Inquiry |
KO17889 | ESCO2 Knockout cell line (HCT 116) | Human | ESCO2 | 1:2~1:4 | Negative | Online Inquiry |
KO17890 | ESCO2 Knockout cell line (HEK293) | Human | ESCO2 | 1:3~1:6 | Negative | Online Inquiry |
KO17891 | ESCO2 Knockout cell line (A549) | Human | ESCO2 | 1:3~1:4 | Negative | Online Inquiry |
ESCO2 Gene Knockout Cell Lines are genetically modified cell lines designed to elucidate the role of the ESCO2 gene, which is critical for proper mitotic chromosome cohesion and genomic stability. By specifically knocking out this gene, researchers can investigate its contributions to various cellular processes, including cell cycle regulation, DNA repair, and the mechanisms underlying chromosomal disorders. These knockout cell lines employ the CRISPR/Cas9 technology that allows for precise and efficient gene editing, ensuring a reliable experimental framework for examining the implications of ESCO2 deficiency.
The key function of the ESCO2 Gene Knockout Cell Lines lies in their ability to mimic pathological states associated with ESCO2 mutations, which are linked to conditions such as Roberts syndrome. This allows researchers to explore cellular mechanisms involved in chromosomal cohesion and integrity. In clinical settings, these models serve as relevant systems for testing potential therapeutic strategies aimed at diseases driven by genomic instability, providing insights that can translate into innovative interventions.
What sets ESCO2 Gene Knockout Cell Lines apart from conventional genetic models is their enhanced specificity and reproducibility, resulting from cutting-edge CRISPR technology. Unlike earlier gene editing methods, the CRISPR/Cas9 approach minimizes off-target effects, thus ensuring the reliability of experimental findings. Additionally, these cell lines have been thoroughly validated, increasing confidence in their use for critical research.
For researchers and clinicians, the value of the ESCO2 Gene Knockout Cell Lines extends beyond basic research; they are an essential tool for the development of new therapeutics and for advancing our understanding of complex genetic disorders. The ability to delineate the biological consequences of gene loss with precision aids in elucidating the pathophysiology underlying various diseases, making these cell lines invaluable for translational research.
Our company prides itself on its commitment to providing high-quality, advanced biological products that empower researchers and clinicians alike. With expertise in genetic engineering and a dedication to innovation, we stand ready to support the scientific community in their quest for knowledge and breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.